Unknown

Dataset Information

0

A plasminogen activator inhibitor-1 inhibitor reduces airway remodeling in a murine model of chronic asthma.


ABSTRACT: We previously reported that plasminogen activator inhibitor (PAI)-1 deficiency prevents collagen deposition in the airways of ovalbumin (OVA)-challenged mice. In this study, we explored the therapeutic utility of blocking PAI-1 in preventing airway remodeling, using a specific PAI-1 inhibitor, tiplaxtinin. C57BL/6J mice were immunized with intraperitoneal injections of OVA on Days 0, 3, and 6. Starting on Day 11, mice were challenged with phosphate-buffered saline or OVA by nebulization three times per week for 4 weeks. Tiplaxtinin was mixed with chow and administered orally from 1 day before the phosphate-buffered saline or OVA challenge. Lung tissues were harvested after challenge and characterized histologically for infiltrating inflammatory cells, mucus-secreting goblet cells, and collagen deposition. Airway hyperresponsiveness was measured using whole-body plethysmography. Tiplaxtinin treatment significantly decreased levels of PAI-1 activity in bronchoalveolar lavage fluids, which indicates successful blockage of PAI-1 activity in the airways. The number of infiltrated inflammatory cells was reduced by tiplaxtinin treatment in the lungs of the OVA-challenged mice. Furthermore, oral administration of tiplaxtinin significantly attenuated the degree of goblet cell hyperplasia and collagen deposition in the airways of the OVA-challenged mice, and methacholine-induced airway hyperresponsiveness was effectively reduced by tiplaxtinin in these animals. This study supports our previous findings that PAI-1 promotes airway remodeling in a murine model of chronic asthma, and suggests that PAI-1 may be a novel target of treatment of airway remodeling in asthma.

SUBMITTER: Lee SH 

PROVIDER: S-EPMC3380292 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

A plasminogen activator inhibitor-1 inhibitor reduces airway remodeling in a murine model of chronic asthma.

Lee Sun H SH   Eren Mesut M   Vaughan Douglas E DE   Schleimer Robert P RP   Cho Seong H SH  

American journal of respiratory cell and molecular biology 20120209 6


We previously reported that plasminogen activator inhibitor (PAI)-1 deficiency prevents collagen deposition in the airways of ovalbumin (OVA)-challenged mice. In this study, we explored the therapeutic utility of blocking PAI-1 in preventing airway remodeling, using a specific PAI-1 inhibitor, tiplaxtinin. C57BL/6J mice were immunized with intraperitoneal injections of OVA on Days 0, 3, and 6. Starting on Day 11, mice were challenged with phosphate-buffered saline or OVA by nebulization three ti  ...[more]

Similar Datasets

| S-EPMC4851936 | biostudies-literature
| S-EPMC2643268 | biostudies-literature
| S-EPMC7407700 | biostudies-literature
| S-EPMC1899277 | biostudies-literature
| S-EPMC3992903 | biostudies-other
| S-EPMC4496537 | biostudies-literature
| S-EPMC4748281 | biostudies-literature
| S-EPMC4929690 | biostudies-literature
| S-EPMC7344209 | biostudies-literature